References
- Plotkin SA. Rubella vaccine. Plotkin SA, Orenstein WA eds. Vaccines. 3rd ed. Philadelphia, Pa: WB Saunders Co; 1998. pp. 409–439.
- Zhu S, Guo C. Rabies control and treatment: from prophylaxis to strategies with curative potential. Viruses. 2016;8(11):279.
- McLaughlin-Drubin ME, Munger K. Viruses associated with human cancer. Biochim Biophys Acta. 2008;1782(3):127–150.
- Schlom J, Hodge JW, Palena C, et al. Therapeutic cancer vaccines. Adv Cancer Res. 2014;121:67–124. •• Considerable importance=discuss how vaccines can be used against cancer.
- World Health Organization. The World Health Report 2000. Health systems: improving performance. Geneva, 2000 (https://www.who.int/whr/2000/en/whr00_en.pdf) last visited 2021 Dec 25)
- Versteeg L, Almutairi MM, Hotez PJ, et al. Enlisting the mRNA vaccine platform to combat parasitic infections. Vaccines (Basel). 2019;7(4):122.
- Fenner F. Global eradication of smallpox. Rev Infect Dis. 1982;4(5):916–930.
- Norrby E, Uhnoo I, Brytting M, et al. Polio close to eradication. Lakartidningen. 2017;114:1–5.
- Hussain SF, Boyle P, Patel P, et al. Eradicating polio in Pakistan: an analysis of the challenges and solutions to this security and health issue. Global Health. 2016;12(1):63.
- Tregoning JS, Brown ES, Cheeseman HM, et al. Vaccines for COVID-19. Clin Exp Immunol. 2020;202(2):162–192.
- Kaur SP, Gupta V. COVID-19 vaccine: a comprehensive status report. Virus Res. 2020;288:198114.
- Callaway E. The race for coronavirus vaccines: a graphical guide. Nature. 2020;580(7805):576–577.
- Adedeji WA. The treasure called antibiotics. Ann Ib Postgrad Med. 2016;14(2):56–57.
- Scollard DM, Adams LB, Gillis TP, et al. The continuing challenges of leprosy. Clin Microbiol Rev. 2006;19(2):338–381.
- Cox FE. Malaria vaccines–progress and problems. Trends Biotechnol. 1991;9(11):389–394. .
- Kumar R, Kumar P. Yeast-based vaccines: new perspective in vaccine development and application. FEMS Yeast Res. 2019;19(2):1-22.
- Oliver SE, Gargano JW, Marin M, et al. The advisory committee on immunization practices’ interim recommendation for use of moderna COVID-19 vaccine - United States, December 2020. MMWR Morb Mortal Wkly Rep. 2021;69(5152):1653–1656.
- Oliver SE, Gargano JW, Marin M, et al. The advisory committee on immunization practices’ interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine - United States. MMWR Morb Mortal Wkly Rep. 2020 [Dec];69(50):1922–1924.
- Park KS, Sun X, Aikins ME, et al. Non-viral COVID-19 vaccine delivery systems. Adv Drug Deliv Rev. 2021;169:137–151.
- Global Vaccine Action plan ( GVAP) https://www.who.int/immunization/global_vaccine_action_plan/en/ last visited 2021 Dec 25)
- Chen X, Fernando GJ, Crichton ML, et al. Improving the reach of vaccines to low-resource regions, with a needle-free vaccine delivery device and long-term thermostabilization. J Control Release. 2011;152(3):349–355.
- Clemens J, Holmgren J, Kaufmann SH, et al. Ten years of the global alliance for vaccines and immunization: challenges and progress. Nat Immunol. 2010;11(12):1069–1072.
- https://ldh.la.gov/assets/oph/Center-PHCH/Center-PH/immunizations/vaccine-storage-handling.pdf (last visited 2021 Dec 25).
- https://www.cdc.gov/vaccines/covid-19/info-by-product/moderna/downloads/storage-summary.pdf (last visited 2021 Dec 25).
- https://www.fda.gov/media/71954/download
- https://www.fda.gov/media/98688/download
- https://www.fda.gov/media/124379/download
- https://www.fda.gov/media/119411/download
- https://www.fda.gov/media/74035/download
- https://www.fda.gov/media/75157/download
- https://www.fda.gov/media/91640/download
- https://www.fda.gov/media/80128/download
- https://www.fda.gov/media/79830/download
- https://www.fda.gov/media/74385/download
- https://www.fda.gov/media/119465/download
- https://www.fda.gov/media/77017/download
- https://www.fda.gov/media/74395/download
- https://www.fda.gov/media/75777/download
- https://www.fda.gov/media/74350/download
- https://www.fda.gov/media/78013/download
- https://www.fda.gov/media/80211/download
- https://www.fda.gov/media/80438/download
- https://www.fda.gov/media/108745/download
- https://www.fda.gov/media/119403/download
- https://www.fda.gov/media/74274/download
- https://www.fda.gov/media/119351/download
- https://www.fda.gov/media/74519/download
- https://www.fda.gov/media/119388/download
- https://www.fda.gov/media/108597/download
- https://www.fda.gov/media/119879/download
- https://www.fda.gov/media/90064/download
- https://www.fda.gov/media/115785/download
- https://www.fda.gov/media/119856/download
- https://www.fda.gov/media/115744/download
- https://www.fda.gov/media/83072/download
- https://www.fda.gov/media/123144/download
- https://www.fda.gov/media/85322/download
- https://www.fda.gov/media/116102/download
- https://www.fda.gov/media/119870/download
- https://www.fda.gov/media/106170/download
- https://www.fda.gov/vaccines-blood-biologics/vaccines/agriflu
- https://www.fda.gov/media/75156/download
- https://www.fda.gov/media/84804/download
- https://www.fda.gov/vaccines-blood-biologics/vaccines/flumist
- https://www.fda.gov/media/74537/download
- https://www.fda.gov/media/81559/download
- https://www.fda.gov/media/115862/download
- https://www.fda.gov/media/117022/download
- https://www.fda.gov/media/94583/download
- https://www.fda.gov/media/87479/download
- https://www.fda.gov/media/74534/download
- https://www.fda.gov/media/77474/download
- https://www.fda.gov/media/77422/download
- https://www.fda.gov/media/77835/download
- https://www.fda.gov/media/77482/download
- https://www.fda.gov/media/77464/download
- https://www.fda.gov/media/78514/download
- https://www.fda.gov/media/89936/download
- https://www.fda.gov/media/90996/download
- https://www.fda.gov/media/75619/download
- https://www.fda.gov/media/75191/download
- https://www.fda.gov/media/75195/download
- https://www.fda.gov/media/83562/download
- https://www.fda.gov/media/107657/download
- https://www.fda.gov/media/80547/download
- https://www.fda.gov/media/75695/download
- https://www.fda.gov/media/83874/download
- https://www.fda.gov/media/75709/download
- https://www.fda.gov/media/75718/download
- https://www.fda.gov/media/75726/download
- https://www.fda.gov/media/75792/download
- https://www.fda.gov/media/76610/download
- https://www.fda.gov/media/76430/download
- https://www.fda.gov/media/119862/download
- https://www.fda.gov/media/124002/download
- https://www.fda.gov/media/78331/download
- https://www.fda.gov/media/76396/download143
- https://www.fda.gov/media/75993/download
- https://www.fda.gov/media/75988/download
- https://www.fda.gov/media/119865/download
- https://www.fda.gov/media/76015/download
- Brandau D, Jones L, Wiethoff C, et al. Thermal stability of vaccines. J Pharm Sci. 2003;92(2):218–231.
- Hill A, Kilgore C, McGlynn M, et al. Improving global vaccine accessibility. Curr Opin Biotechnol. 2016;42:67–73.
- Chen D, Kristensen D. Opportunities and challenges of developing thermostable vaccines. Expert Rev Vaccines. 2009;8(5):547–557.
- Wirkas T, Toikilik S, Miller N, et al. A vaccine cold chain freezing study in PNG highlights technology needs for hot climate countries. Vaccine. 2007;25(4):691–697.
- Das P. Revolutionary vaccine technology breaks the cold chain. Lancet Infect Dis. 2004;4(12):719.
- Lee BY, Cakouros BE, Assi TM, et al. The impact of making vaccines thermostable in niger’s vaccine supply chain. Vaccine. 2012;30(38):5637–5643.
- Peetermans J. Factors affecting the stability of viral vaccines. Dev Biol Stand. 1996;87:97–101.
- Lloyd J, Lydon P, Ouhichi R, et al. Reducing the loss of vaccines from accidental freezing in the cold chain: the experience of continuous temperature monitoring in Tunisia. Vaccine. 2015;33(7):902–907.
- Kumru O, Joshi SB, Smith DE, et al. Vaccine instability in the cold chain: mechanisms, analysis and formulation strategies. Biologicals. 2014;42(5):237–259.
- Gupta CK, Leszczynski J, Gupta RK, et al. Stabilization of respiratory syncytial virus (RSV) against thermal inactivation and freeze-thaw cycles for development and control of RSV vaccines and immune globulin.vaccine1996. Vaccine. 1996;14(15):1417–1420.
- Galazka A, Milstien J, Zaffran M. Thermostability of vaccines: global programme for vaccines and immunization. Geneva: World Health Organization; 1998.
- https://vaccine-safety-training.org/vaccine-components.html (last visited 2021 Dec 25).
- Walker SE, Iazzetta J, Law S, et al. Stability of commonly used antibiotic solutions in an elastomeric infusion device. Can J Hosp Pharm. 2010;63(3):212–224.
- Holmes CJ, Ausman RK, Walter CW, et al. Activity of antibiotic admixtures subjected to different freeze-thaw treatments. Drug Intell Clin Pharm. 1980;14(5):353–357.
- Agarwal S, Hickey JM, McAdams D, et al. Effect of aluminum adjuvant and preservatives on structural integrity and physicochemical stability profiles of three recombinant subunit rotavirus vaccine antigens. J Pharm Sci. 2020;109(1):476–487.
- Clapp T, Siebert P, Chen D, et al. Vaccines with aluminum-containing adjuvants: optimizing vaccine efficacy and thermal stability. J Pharm Sci. 2011;100(2):388–401.
- HogenEsch H, O’Hagan DT, Fox CB. Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want. NPJ Vaccines. 2018;3(1):51.
- Adams GD. Lyophilization of vaccines: current trends. Methods Mol Med. 2003;87:223–244.
- Sharma A, Preece B, Swann H, et al. Structural stability of SARS-CoV-2 virus like particles degrades with temperature. Biochem Biophys Res Commun. 2021;534:343–346.
- Ausar SF, Foubert TR, Hudson MH, et al. Conformational stability and disassembly of Norwalk virus-like particles. Effect of pH and temperature. J Biol Chem. 2006;281(28):19478–19488.
- Corbel MJ. Reasons for instability of bacterial vaccine. Dev Biol Stand. 1996;87:113–124.
- Schellman JA. Temperature, stability, and the hydrophobic interaction. Biophys J. 1997;73(6):2960–2964.
- Lu FS, Bruheim I, Haugsgjerd BO, et al. Effect of temperature towards lipid oxidation and non-enzymatic browning reactions in krill oil upon storage. Food Chem. 2014;157:398–407.
- Wolfson LJ, Gasse F, Lee-Martin SP, et al. Estimating the costs of achieving the WHO-UNICEF global immunization vision and strategy, 2006-2015. Bull World Health Organ. 2008;86(1):27–39.
- https://view-hub.org/covid-19/characteristics/
- https://www.cdc.gov/vaccines/covid-19/info-by-product/janssen/downloads/janssen-storage-handling-summary.pdf last visited on 2021 Dec 24)
- Ward BJ, Gobeil P, Séguin A, et al. Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19. Nat Med. 2021;27(6):1071–1078.
- Braun LJ, Jezek J, Peterson S, et al. Characterization of a thermostable hepatitis B vaccine formulation. Vaccine. 2009;27(34):4609–4614.
- Autumn Smiley M, Sanford DC, Triplett CA, et al. Comparative immunogenicity and efficacy of thermostable (lyophilized) and liquid formulation of anthrax vaccine candidate AV7909. Vaccine. 2019;37(43):6356–6361.
- Shin WJ, Hara D, Gbormittah F, et al. Development of thermostable lyophilized sabin inactivated poliovirus vaccine. mBio. 2018;9(6):e02287–18.
- Wang SH, Kirwan SM, Abraham SN, et al. Stable dry powder formulation for nasal delivery of anthrax vaccine. J Pharm Sci. 2012;101(1):31–47.
- Maa YF, Ameri M, Shu C, et al. Influenza vaccine powder formulation development: spray-freeze-drying and stability evaluation. J Pharm Sci. 2004;93(7):1912–1923.
- Garmise RJ, Staats HF, Hickey AJ. Novel dry powder preparations of whole inactivated influenza virus for nasal vaccination. AAPS Pharm Sci Tech. 2007;8(4):2–10.
- Chisholm CF, Kang TJ, Dong M, et al. Thermostable Ebola virus vaccine formulations lyophilized in the presence of aluminum hydroxide. Eur J Pharm Biopharm. 2019;136:213–220.
- Stitz L, Vogel A, Schnee M, et al. A thermostable messenger RNA based vaccine against rabies. PLoS Negl Trop Dis. 2017;11(12):e0006108.
- Kramer RM, Archer MC, Orr MT, et al. Development of a thermostable nanoemulsion adjuvanted vaccine against tuberculosis using a design-of-experiments approach. Int J Nanomedicine. 2018;13:3689–3711.
- Kunda NK, Peabody J, Zhai L, et al. Evaluation of the thermal stability and the protective efficacy of spray-dried HPV vaccine, Gardasil 9. Hum Vaccin Immunother. 2019;15(7–8):1995–2002.
- Kanojia G, Raeven RHM, van der Maas L, et al. Development of a thermostable spray dried outer membrane vesicle pertussis vaccine for pulmonary immunization. J Control Release. 2018;286:167–178.
- Chen D, Kapre S, Goel A, et al. Thermostable formulations of a hepatitis B vaccine and a meningitis A polysaccharide conjugate vaccine produced by a spray drying method. Vaccine. 2010;28(31):5093–5099.
- Smith TG, Siirin M, Wu X, et al. Rabies vaccine preserved by vaporization is thermostable and immunogenic. Vaccine. 2015;33(19):2203–2206.
- Luczo JM, Bousse T, Johnson SK, et al. Intranasal powder live attenuated influenza vaccine is thermostable, immunogenic, and protective against homologous challenge in ferrets. Npj Vaccines. 2021;6(1):59.
- https://www.who.int/immunization/documents/WHO_IVB_06.10/en/
- Wang G, Cao RY, Chen R, et al. Rational design of thermostable vaccines by engineered peptide-induced virus self-biomineralization under physiological conditions. Proc Natl Acad Sci USA. 2013;110(19):7619–7624.
- Min Y, Xu W, Xiao Y, et al. Biomineralization improves the stability of a streptococcus pneumoniae protein vaccine at high temperatures. Nanomedicine (Lond). 2021;16(20):1747–1761.
- Leung V, Mapletoft J, Zhang A, et al. Thermal stabilization of viral vaccines in low-cost sugar films. Sci Rep. 2019;9(1):7631.
- Bajrovic I, Schafer SC, Romanovicz DK, et al. Novel technology for storage and distribution of live vaccines and other biological medicines at ambient temperature. Sci Adv. 2020;6(10): eaau4819.
- Alcock R, Cottingham MG, Rollier CS, et al. Long-term thermo stabilization of live poxviral and adenoviral vaccine vectors at supraphysiological temperatures in carbohydrate glass. Sci Transl Med. 2010;2(19):19ra12.
- Hensley C, Zhou P, Schnur S, et al. Thermostable, dissolvable buccal film rotavirus vaccine is highly effective in neonatal gnotobiotic pig challenge model. Vaccines (Basel). 2021;9(5):437.
- Zhou H, Wang G, Li XF, et al. Alumina-encapsulated vaccine formulation with improved thermostability and immunogenicity. Chem Commun (Camb). 2016;52(38):6447–6450.
- Wambura PN. Formulation of novel nano-encapsulated Newcastle disease vaccine tablets for vaccination of village chickens. Trop Anim Health Prod. 2011;43(1):165–169.
- Zhang NN, Li XF, Deng YQ, et al. A thermostable mRNA vaccine against COVID-19. Cell. 2020;182(5):1271–1283.
- Chen Y, Smith T, Hicks RH, et al. Thermal stability, storage and release of proteins with tailored fit in silica. Sci Rep. 2017;7(1):46568.
- Wahid AA, Doekhie A, Sartbaeva A, et al. Ensilication improves the thermal stability of the tuberculosis antigen Ag85b and an Sbi-Ag85b vaccine conjugate. Sci Rep. 2019;9(1):11409.
- Doekhie A, Dattani R, Chen YC, et al. Ensilicated tetanus antigen retains immunogenicity: in vivo study and time-resolved SAXS characterization. Sci Rep. 2020;10(1):9243.
- Mistilis MJ, Bommarius AS, Prausnitz MR. Development of a thermostable microneedle patch for influenza vaccination. J Pharm Sci. 2015;104(2):740–749.
- Vrdoljak A, Allen EA, Ferrara F, et al. Induction of broad immunity by thermostabilised vaccines incorporated in dissolvable microneedles using novel fabrication methods. J Control Release. 2016;225:192–204.
- Poirier D, Renaud F, Dewar V, et al. Hepatitis B surface antigen incorporated in dissolvable microneedle array patch is antigenic and thermostable. Biomaterials. 2017;145:256–265.
- Kolluru C, Gomaa Y, Prausnitz MR. Development of a thermostable microneedle patch for polio vaccination. Drug Deliv Transl Res. 2019;9(1):192–203.
- Prausnitz MR, Mikszta JA, Cormier M, et al. Microneedle-based vaccines. Curr Top Microbiol Immunol. 2009;333:369–393.
- Shin CI, Jeong SD, Rejinold NS, et al. Microneedles for vaccine delivery: challenges and future perspectives. Ther Deliv. 2017;8(6):447–460.
- Garcea RL, Meinerz NM, Dong M, et al. Single-administration, thermostable human papillomavirus vaccines prepared with atomic layer deposition technology. NPJ Vaccines. 2020;5(1):45.
- Rossi R, Konar M, Beernink P. Meningococcal factor H binding protein vaccine antigens with increased thermal stability and decreased binding of human factor H. Infect Immun. 2016;84(6):1735–1742.
- Konar M, Pajon R, Beernink P. A meningococcal vaccine antigen engineered to increase thermal stability and stabilize protective epitopes. Proc Natl Acad Sci USA. 2015;112(48):14823–14828.
- Crecente-Campo J, Lorenzo-Abalde S, Mora A, et al. Bilayer polymeric nanocapsules: a formulation approach for a thermostable and adjuvanted E. coli antigen vaccine. J Control Release. 2018;286:20–32.
- Wang G, Zhou H, Nian QG, et al. Robust vaccine formulation produced by assembling a hybrid coating of polyethyleneimine-silica. Chem Sci. 2016;7(3):1753–1759.
- Dulal P, Wright D, Ashfield R, et al. Potency of a thermostabilised chimpanzee adenovirus rift valley fever vaccine in cattle. Vaccine. 2016;34(20):2296–2298.
- Kumar R. Investigating the long-term stability of protein immunogen(s) for whole recombinant yeast-based vaccines. FEMS Yeast Res. 2018;18(7):1–13.
- Kumar R, Kharbikar BN. Lyophilized yeast powder for adjuvant free thermostable vaccine delivery. Appl Microbiol Biotechnol. 2021;105(8):3131–3143.
- DeMaria PJ, Bilusic M, Park DM, et al. Randomized, double-blind, placebo-controlled phase II study of yeast-brachyury vaccine (GI-6301) in combination with standard-of-care radiotherapy in locally advanced, unresectable chordoma. Oncologist. 2021;26(5):e847–e858.
- Bolhassani A, Muller M, Roohvand F, et al. Whole recombinant pichia pastoris expressing HPV16 L1 antigen is superior in inducing protection against tumor growth as compared to killed transgenic leishmania. Hum Vaccin Immunother. 2014;10(12):3499–3508.
- Stubbs AC, Martin KS, Coeshott C, et al. Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell-mediated immunity. Nat Med. 2001;7(5): 625–629.
- Soto E, Kim YS, Lee J, et al. Glucan particle encapsulated rifampicin for targeted delivery to macrophages. Polymers. 2010;2(4):681–689.
- Tesz GJ, Aouadi M, Prot M, et al. Glucan particles for selective delivery of siRNA to phagocytic cells in mice. Biochem J. 2011;436(2):351–362.
- Croyle MA, Cheng X, Wilson JM. Development of formulations that enhance physical stability of viral vectors for gene therapy. Gene Ther. 2001;8(17):1281–1290.
- Croyle MA, Roessler BJ, Davidson BL, et al. Factors that influence stability of recombinant adenoviral preparations for human gene therapy. Pharm Dev Technol. 1998;3(3):373–383.
- Milistien JB, Stanley ML, Peter FW. Development of a more thermostable poliovirus vaccine. J Infect Dis. 1997;175(Suppl 1):S247–S253.
- Evans RK, Nawrocki DK, Isopi LA, et al. Development of stable liquid formulations for adenovirus-based vaccines. J Pharm Sci C. 2004;93(10):2458–2475.
- Rexroad J, Wiethoff CM, Green AP, et al. Structural stability of adenovirus type 5. J Pharm Sci. 2003;92(3):665–678.
- Stewart M, Ward SJ, Drew J. Use of adenovirus as a model system to illustrate a simple method using standard equipment and in expensive excipients to remove live virus dependence on the cold-chain. Vaccine. 2014;32(24):2931–2938.
- Pelliccia M, Andreozzi P, Paulose J, et al. Additives for vaccine storage to improve thermal stability of adenoviruses from hours to months. Nat Commun. 2016;7(1):13520.
- Schlehuber LD, McFadyen IJ, Shu Y, et al. Towards ambient temperature-stable vaccines: the identification of thermally stabilizing liquid formulations for measles virus using an innovative high-throughput infectivity assay. Vaccine. 2011;29(31):5031–5039.
- Phadke R, Dos Santos Costa AC, Dapke K, et al. Eco-friendly vaccination: tackling an unforeseen adverse effect. 2021;1:1000.J Clim Chang Health
- Sarkodie SA, Owusu PA. Impact of COVID-19 pandemic on waste management. Environ Dev Sustain. 2020 ;23:1–10.
- Das AK, Islam MN, Billah MM, et al. COVID-19 pandemic and healthcare solid waste management strategy - A mini-review. Sci Total Environ. 2021;778:146220.
- https://www.theguardian.com/world/2021/feb/10/japan-pfizer-vaccine-doses-wrong-syringes last visited on 2021 Dec 25)
- https://www.aljazeera.com/news/2021/2/16/syringe-shortage-hampers-japans-covid-19-vaccination-drive last visited on 2021 Dec 25)
- https://www.npr.org/2021/02/11/966712940/short-on-syringes-japan-may-waste-millions-of-pfizer-vaccine-doses last visited on 2021 Dec 25)
- Gunasekaran B, Gothandam KM. A review on edible vaccines and their prospects. Braz J Med Biol Res. 2020;53(2):e8749.
- Sahoo A, Mandal AK, Dwivedi K, et al. A cross talk between the immunization and edible vaccine: current challenges and future prospects. Life Sci. 2020;261:118343.
- https://www.electricchoice.com/blog/worst-power-outages-in-united-states-history/ last visited on 2021 Dec 24)
- https://www.washingtonpost.com/weather/2021/02/16/winter-storm-live-updates/
- https://www.boston25news.com/news/health/nearly-2000-doses-covid-vaccine-spoiled-jamaica-plain-va-facility-after-freezer-unplugged/TWYS7X2LSZACNFGADCE5XTAAOA/ last visited on 2021 Dec 24)
- https://www.cnn.com/2021/01/06/us/california-broken-freezer-vaccines-trnd/index.html last visited on 2021 Dec 24)
- https://www.nbcnews.com/news/us-news/wisconsin-hospital-employee-fired-after-intentionally-destroying-500-doses-covid-n1252605 ( last visited on Dec 24, 2021)